Cristina Larkin

2018

In 2018, Cristina Larkin earned a total compensation of $533.8K as Chief Operating Officer at Spero Therapeutics, a 56% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$148,225
Salary$385,000
Other$574
Total$533,799

Larkin received $385K in salary, accounting for 72% of the total pay in 2018.

Larkin also received $148.2K in non-equity incentive plan and $574 in other compensation.

Rankings

In 2018, Cristina Larkin's compensation ranked 11,662nd out of 14,244 executives tracked by ExecPay. In other words, Larkin earned more than 18.1% of executives.

ClassificationRankingPercentile
All
11,662
out of 14,244
18th
Division
Manufacturing
4,707
out of 5,765
18th
Major group
Chemicals And Allied Products
1,780
out of 2,128
16th
Industry group
Drugs
1,516
out of 1,817
17th
Industry
Pharmaceutical Preparations
1,164
out of 1,391
16th
Source: SEC filing on April 26, 2019.

Larkin's colleagues

We found three more compensation records of executives who worked with Cristina Larkin at Spero Therapeutics in 2018.

2018

David Melnick

Spero Therapeutics

Chief Medical Officer

2018

Ankit Mahadevia

Spero Therapeutics

Chief Executive Officer

2018

Christina Larkin

Spero Therapeutics

Chief Operating Officer

News

You may also like